Skip to main content
. 2020 Dec 3;10:21033. doi: 10.1038/s41598-020-78207-3

Figure 2.

Figure 2

Network analysis combining focused proteins (colored) that correspond to differentially expressed proteins in late-onset fetal growth restriction (green: underexpressed, red: overexpressed) and non-focused proteins that were added by Ingenuity, using knowledge derived data from their own database. ABCG2 ATP-binding cassette sub-family G member 2, ADIPOQ Adiponectin, APOC2 apolipoprotein C-II, APOC3 apolipoprotein C-III, APOE apolipoprotein E, BCL2 B-cell lymphoma 2, CD209 cluster of differentiation 209, CHKA choline kinase alpha, CRYAB alpha-crystallin B chain, CTBS Di-N-acetylchitobiase, EGF epidermal growth factor, EGFR epidermal growth factor receptor, ENAH protein enabled homolog, ESR1 estrogen receptor 1, FABP5 fatty acid-binding protein 5, GP1BA platelet glyprotein Ib alpha chain, GPER1 G-protein coupled estrogen receptor 1, LGALS3BP galectin-3-binding protein, LGALS7 galectin-7, LTF lactotransferrin, LYVE1 lymphatic vessel endothelial hyaluronan receptor 1, NOTCH1 neurogenic locus notch homolog protein 1, P85 (pirk3r) phosphatidylinositol 3-kinase, PGR progesterone receptor, PLTP Phospholipid transfer protein, PPARG peroxisome proliferator-activated receptor gamma, PSG9 pregnancy-specific beta-1-glyprotein 9, PTPN9 protein tyrosine phosphatase, non-receptor type 9, PTPRK protein tyrosine phosphatase receptor type K, RARA retinoic acid receptor alpha, SAA serum amyloid A, SDCBP syndecan binding protein, STAT3 signal transducer and activator of transcription 3, TAGLN2 transgelin-2, TP53 tumor protein p53.